title: Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia.
abstract: The neuroprotective effect of neuropeptide Y (NPY) receptor activation was investigated in organotypic mouse hippocampal slice cultures exposed to the glutamate receptor agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA). Exposure of 2-week-old slice cultures, derived from 7-day-old C57BL/6 mice, to 8 microm AMPA, for 24 h, induced degeneration of CA1 and CA3 pyramidal cells, as measured by cellular uptake of propidium iodide (PI). A significant neuroprotection, with a reduction of PI uptake in CA1 and CA3 pyramidal cell layers, was observed after incubation with a Y(2) receptor agonist [NPY(13-36), 300 nm]. This effect was sensitive to the presence of the selective Y(2) receptor antagonist (BIIE0246, 1 microm), but was not affected by addition of TrkB-Fc or by a neutralizing antibody against brain-derived neurotrophic factor (BDNF). Moreover, addition of a Y(1) receptor antagonist (BIBP3226, 1 microm) or a NPY-neutralizing antibody helped to disclose a neuroprotective role of endogenous NPY in CA1 region. Cultures exposed to 8 microm AMPA for 24 h, displayed, as measured by an enzyme-linked immunosorbent assay, a significant increase in BDNF. In such cultures there was an up-regulation of neuronal TrkB immunoreactivity, as well as the presence of BDNF-immunoreactive microglial cells at sites of injury. Thus, an increase of AMPA-receptor mediated neurodegeneration, in the mouse hippocampus, was prevented by neuroprotective pathways activated by NPY receptors (Y(1) and Y(2)), which can be affected by BDNF released by microglia and neurons.
authors.affiliation: Center for Neuroscience and Cell Biology of Coimbra and Institute of Biochemistry, Faculty of Medicine, University of Coimbra, 3004-504 Coimbra, Portugal.
authors.forename: S
authors.initials: S
authors.lastname: Xapelli
authors.forename: L
authors.initials: L
authors.lastname: Bernardino
authors.forename: R
authors.initials: R
authors.lastname: Ferreira
authors.forename: S
authors.initials: S
authors.lastname: Grade
authors.forename: A P
authors.initials: AP
authors.lastname: Silva
authors.forename: J R
authors.initials: JR
authors.lastname: Salgado
authors.forename: C
authors.initials: C
authors.lastname: Cavadas
authors.forename: E
authors.initials: E
authors.lastname: Grouzmann
authors.forename: F R
authors.initials: FR
authors.lastname: Poulsen
authors.forename: B
authors.initials: B
authors.lastname: Jakobsen
authors.forename: C R
authors.initials: CR
authors.lastname: Oliveira
authors.forename: J
authors.initials: J
authors.lastname: Zimmer
authors.forename: J O
authors.initials: JO
authors.lastname: Malva
mesh_terms: D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D006624:Hippocampus / Q000378:metabolism; D007150:Immunohistochemistry; D051379:Mice; D008810:Mice, Inbred C57BL; D017628:Microglia / Q000378:metabolism*; D009474:Neurons / Q000378:metabolism*; D009478:Neuropeptide Y / Q000378:metabolism*; D009924:Organ Culture Techniques; D018091:Receptors, AMPA / Q000378:metabolism; D017476:Receptors, Neuropeptide Y / Q000037:antagonists & inhibitors / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D019208:Brain-Derived Neurotrophic Factor; D009478:Neuropeptide Y; D018091:Receptors, AMPA; D017476:Receptors, Neuropeptide Y